Wai Yuen Tong Medicine Holdings Limited (HKG:0897)
Hong Kong
· Delayed Price · Currency is HKD 0.3450
+0.0100 (2.99%)
Jun 30, 2025, 3:00 PM HKT
HKG:0897 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 745.3 | 783.88 | 723.6 | 1,391 | 1,109 | Upgrade
| |
Revenue Growth (YoY) | -4.92% | 8.33% | -47.99% | 25.52% | 78.59% | Upgrade
|
Cost of Revenue | 368.85 | 389.07 | 381.24 | 817.26 | 666.63 | Upgrade
|
Gross Profit | 376.45 | 394.81 | 342.36 | 574.15 | 441.93 | Upgrade
|
Selling, General & Admin | 408.3 | 354.98 | 331.52 | 499.2 | 429.26 | Upgrade
|
Operating Expenses | 408.3 | 353.93 | 337.37 | 504.58 | 428.1 | Upgrade
|
Operating Income | -31.85 | 40.88 | 4.99 | 69.58 | 13.83 | Upgrade
|
Interest Expense | -28.16 | -40.79 | -29.51 | -95.7 | -107.72 | Upgrade
|
Interest & Investment Income | - | 48.24 | 47.13 | 25.35 | 29.66 | Upgrade
|
Earnings From Equity Investments | 1.05 | 2.53 | 2.95 | 1.57 | 4.65 | Upgrade
|
Currency Exchange Gain (Loss) | - | -2.63 | -3.71 | 6.97 | 2.07 | Upgrade
|
Other Non Operating Income (Expenses) | 73.49 | 7.91 | 5.06 | 55.29 | 72.57 | Upgrade
|
EBT Excluding Unusual Items | 14.52 | 56.14 | 26.92 | 63.06 | 15.06 | Upgrade
|
Gain (Loss) on Sale of Investments | -6.5 | -12.83 | -11.6 | -78.07 | -232 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 29.5 | -1.48 | 1.81 | -0.24 | Upgrade
|
Asset Writedown | -3.95 | -86.48 | -20.13 | -80.62 | -56.95 | Upgrade
|
Legal Settlements | - | - | - | 48.57 | - | Upgrade
|
Other Unusual Items | - | 0.04 | 0.39 | -2.06 | -29.01 | Upgrade
|
Pretax Income | 4.08 | -13.63 | -5.91 | -47.3 | -303.13 | Upgrade
|
Income Tax Expense | -3.02 | -6.36 | -13.32 | 40.52 | 148.13 | Upgrade
|
Earnings From Continuing Operations | 7.09 | -7.27 | 7.41 | -87.82 | -451.26 | Upgrade
|
Earnings From Discontinued Operations | - | 11.32 | -4.07 | - | - | Upgrade
|
Net Income to Company | 7.09 | 4.05 | 3.35 | -87.82 | -451.26 | Upgrade
|
Minority Interest in Earnings | 0.01 | -19.4 | -23.86 | -21.09 | 75.27 | Upgrade
|
Net Income | 7.1 | -15.36 | -20.52 | -108.91 | -376 | Upgrade
|
Net Income to Common | 7.1 | -15.36 | -20.52 | -108.91 | -376 | Upgrade
|
Shares Outstanding (Basic) | 1,127 | 1,181 | 1,216 | 1,232 | 1,232 | Upgrade
|
Shares Outstanding (Diluted) | 1,127 | 1,181 | 1,216 | 1,232 | 1,232 | Upgrade
|
Shares Change (YoY) | -4.60% | -2.87% | -1.25% | - | - | Upgrade
|
EPS (Basic) | 0.01 | -0.01 | -0.02 | -0.09 | -0.31 | Upgrade
|
EPS (Diluted) | 0.01 | -0.01 | -0.02 | -0.09 | -0.31 | Upgrade
|
Free Cash Flow | - | 157.04 | 134.89 | 143.07 | 353.05 | Upgrade
|
Free Cash Flow Per Share | - | 0.13 | 0.11 | 0.12 | 0.29 | Upgrade
|
Dividend Per Share | - | 0.030 | - | - | - | Upgrade
|
Gross Margin | 50.51% | 50.37% | 47.31% | 41.26% | 39.87% | Upgrade
|
Operating Margin | -4.27% | 5.21% | 0.69% | 5.00% | 1.25% | Upgrade
|
Profit Margin | 0.95% | -1.96% | -2.83% | -7.83% | -33.92% | Upgrade
|
Free Cash Flow Margin | - | 20.03% | 18.64% | 10.28% | 31.85% | Upgrade
|
EBITDA | 19.85 | 92.58 | 59.6 | 130.58 | 72.83 | Upgrade
|
EBITDA Margin | 2.66% | 11.81% | 8.24% | 9.38% | 6.57% | Upgrade
|
D&A For EBITDA | 51.7 | 51.7 | 54.61 | 61 | 59 | Upgrade
|
EBIT | -31.85 | 40.88 | 4.99 | 69.58 | 13.83 | Upgrade
|
EBIT Margin | -4.27% | 5.21% | 0.69% | 5.00% | 1.25% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.